Difficulty: Medium
Average Score: 91%
Practice
Colchicine may be an effective drug to prevent the development of AA amyloidosis in which of the following diseases?
Correct answer
C
Rationale
The correct answer is C) familial Mediterranean fever. Colchicine is known to be effective in preventing the development of AA amyloidosis in patients with familial Mediterranean fever. This is because familial Mediterranean fever is an autoinflammatory disorder characterized by recurrent attacks of fever and inflammation, which can lead to the deposition of amyloid proteins in various tissues.
Option A) juvenile idiopathic arthritis is incorrect because colchicine is not typically used in the treatment or prevention of AA amyloidosis associated with this condition. Juvenile idiopathic arthritis is managed using other medications like nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs).
Option B) ankylosing spondylitis is also incorrect as colchicine is not a standard treatment for this condition. Ankylosing spondylitis is usually managed with NSAIDs, physical therapy, and in some cases, biologic medications targeting specific inflammatory pathways.
Option D) hyper IgD syndrome is not associated with the development of AA amyloidosis, and colchicine is not commonly used in its management. Hyper IgD syndrome is a rare autoinflammatory disorder characterized by recurrent fevers, lymphadenopathy, and elevated IgD levels, and its treatment typically involves anti-inflammatory medications and sometimes biologics.
In an educational context, understanding the appropriate use of medications in different diseases is crucial for healthcare providers, especially pediatric nurses working with children with complex medical conditions. Knowing the indications and contraindications of drugs like colchicine can help nurses provide safe and effective care to pediatric patients with conditions like familial Mediterranean fever.
Option A) juvenile idiopathic arthritis is incorrect because colchicine is not typically used in the treatment or prevention of AA amyloidosis associated with this condition. Juvenile idiopathic arthritis is managed using other medications like nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs).
Option B) ankylosing spondylitis is also incorrect as colchicine is not a standard treatment for this condition. Ankylosing spondylitis is usually managed with NSAIDs, physical therapy, and in some cases, biologic medications targeting specific inflammatory pathways.
Option D) hyper IgD syndrome is not associated with the development of AA amyloidosis, and colchicine is not commonly used in its management. Hyper IgD syndrome is a rare autoinflammatory disorder characterized by recurrent fevers, lymphadenopathy, and elevated IgD levels, and its treatment typically involves anti-inflammatory medications and sometimes biologics.
In an educational context, understanding the appropriate use of medications in different diseases is crucial for healthcare providers, especially pediatric nurses working with children with complex medical conditions. Knowing the indications and contraindications of drugs like colchicine can help nurses provide safe and effective care to pediatric patients with conditions like familial Mediterranean fever.